4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-001284
Chief Development Officer acquired 38,750 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| See Tai Sandi Chief Development Officer | 2025-01-07 | Grant or award | +38,750 | 55,375 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| See Tai Sandi Chief Development Officer | 2025-01-07 | Grant or award · Stock Option (right to buy) | +77,500 | 77,500 | D: show line 2 in the form |
Loading xslF345X05/form4-01102025_040103.xml…